The following questionnaire is required to define whether HSCT is a meaningful and safe treatment option.


Advanced therapy with AHSCT against Multiple Sclerosis

Advanced therapy with AHSCT for MS patients

Moscow Department of Hematology and Cellular Therapy


General rules after discharge

The following questionnaire is required to define your condition after AHSCT.


Russia Against Multiple Sclerosis

Professor of the Department of Hematology and Cellular Therapy. A.A. Maksimova


Webinar record and questions of participants